Figure 4.
The IBMTR experience of chronic myelogenous leukemia (CML) chronic phase patients.
The curves demonstrate both the effect of a related versus unrelated donor, and the benefit of early transplantation on survival (Figure 4 reprinted with permission from the IBMTR).
